Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_assertion type Assertion NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_head.
- NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_assertion description "[To examine the potential of SOX-4 for broad use as a lung cancer vaccine, we have evaluated the expression of SOX-4 in a panel of primary adenocarcinoma, squamous, and large cell tumor samples as well as in a panel of established small cell and non-small cell lung carcinoma tumor cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_provenance.
- NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_assertion evidence source_evidence_literature NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_provenance.
- NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_assertion SIO_000772 14978140 NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_provenance.
- NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_assertion wasDerivedFrom befree-20140225 NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_provenance.
- NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_assertion wasGeneratedBy ECO_0000203 NP763269.RAuEkUZdxu26iAQQP0iQ2JXe2PIEF404INkMJd2VnNYCQ130_provenance.